Search
for
Sort by
Research 121–150 of 227
- Immune therapies for alopecia areata: evidence and new perspectives
- Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients with APS-1
- Tofacitinib Treatment in Patients With Active COVID-19 Infection
- Alopecia areata – Aktuelles Verständnis und Management
- Dermal T cell immunity and key regulatory signaling pathways: Implications in immune-mediated alopecia and hair regeneration
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- Advances in the mechanism and new therapies of alopecia areata
- Referee report. For: Molecular mediators involved in skin healing: a narrative review [version 1; peer review: 1 approved with reservations]
- Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape
- DataSheet1_Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention.PDF
- Updates From 2021 Virtual Dermatology Nurses' Association Convention
- Diagnostic Challenges and Treatment Strategies in Neutrophilic Cicatricial Alopecias: A Narrative Review from Conventional Therapies to New Therapeutic Targets
- Biologics in the management of childhood atopic dermatitis
- Poster Presentations
- 42004 Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study
- Topical Ruxolitinib in Combination with Oral Minoxidil Results in Hair Regrowth in a Patient with Central Centrifugal Cicatricial Alopecia and Concomitant Traction Alopecia
- Drugs targeting the JAK/STAT pathway for the treatment of immune-mediated inflammatory skin diseases: protocol for a scoping review
- Androgens/Androgen Receptor in the Management of Skin Diseases
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- Case Report: Baricitinib improved alopecia areata in a pediatric patient with atopic dermatitis
- An Updated in the Management of Alopecia Areata
- Recent Advances in Understanding of the Etiopathogenesis, Diagnosis, and Management of Hair Loss Diseases
- Inhibition of JAK-STAT Signaling with Baricitinib Reduces Inflammation and Improves Cellular Homeostasis in Progeria Cells
- Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
- Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Topical Delivery of Tofacitinib in Dermatology: The Promise of a Novel Therapeutic Class Using Biodegradable Dendritic Polyglycerol Sulfates
- Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata